Micro I agree with most of you points except one..

Micro I agree with most of you points except one..."most of the handwringing re Rogers is unnecessary -as Mach said the only thing he saw Rogers enabling was in the general area of marketing etc"

Marketing for this company, especially with a patent pending for covid is the name of the game. If you can't market your product you don't sell and the company and shareholders go nowhere. NDA's are nice but we've seen these before and nothing evolved.

I've tried several times to get in touch with Biomotiv to talk to Rogers and see if he is even still with the company. They must be teleworking because no one answers their phones and it's always busy when trying to get the office administrator. They even have a PR person to contact for press related interviews and that phone number is always busy 24/7...seems to me they may possibly be out of business. Even though this company deals mostly with pharmaceuticals a chance to get into the covid diagnostics arena would certainly seem enticing. They are adept at finding funding and partners and I'm wondering if Bret considered using them in the first place. Just my thoughts.